Publications by authors named "Cintia Maura Caseiro Nigro"
TRANSLATION, CROSS-CULTURAL ADAPTATION, AND VALIDATION OF THE IBD DISK FOR USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN THE BRAZILIAN POPULATION.
Cintia Maura Caseiro Nigro Sandro da Costa Ferreira Vanessa Foresto Machado Marley Ribeiro Feitosa José Joaquim Ribeiro da Rocha
Arq Gastroenterol
January 2025
Background: The inflammatory bowel disease (IBD) disk is a simple and quick method to assess the level of disability experienced by patients with IBD. It has been already translated and validated in European countries, however it was not yet translated and validated to use in Brazil.
Objective: This study was performed to translate and validate a Brazilian version of the IBD-Disk.
Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study.
Rogério Serafim Parra Júlio Maria Fonseca Chebli Liliana Andrade Chebli Sérgio Figueiredo de Lima Junior Manoel Alvaro Lins Neto Cintia Maura Caseiro Nigro
J Clin Med
April 2023
Article Synopsis
- This study examines cases of leukocytoclastic vasculitis (LCV) linked to anti-tumor necrosis factor (TNF) therapy in patients with inflammatory bowel disease (IBD), highlighting it as a rare complication.
- Out of 2442 assessed IBD patients, five (0.6%) were identified with LCV, mainly affecting women aged around 32 who were on anti-TNF medications like adalimumab.
- The study emphasizes the importance of recognizing unexplained skin rashes as potential signs of LCV in IBD patients on anti-TNF therapy, as treatment with oral steroids led to complete remission in all cases.
Article Synopsis
- Brazilian patients with inflammatory bowel diseases (IBD) often rely on the National Unified Health Care System (SUS) for access to high-cost biological medications, but their experiences vary regarding availability and quality of provision.
- A survey involving 205 patients revealed that a significant majority experienced issues such as medication shortages, with over 83% reporting at least one failed delivery in the past year.
- Many patients faced considerable delays in receiving their medications, which they believed negatively impacted their treatment, highlighting systemic issues within the public health care framework in Brazil.